Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Ani Pharmaceuticals Inc

NASDAQ: ANIP · Life Sciences · 10 alerts · CIK 1023024

Share price
$70.89Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ani Pharmaceuticals Inc filings on SEC EDGAR ↗

8:01 AM ET 8-K
Investor Presentation

Ani Pharmaceuticals Investor Presentation

ANI Pharmaceuticals published an updated corporate investor presentation for November 2026 to its website. The presentation outlines the company's strategic transformation into a leading rare disease company, including its proposed acquisition of Egetis Therapeutics and growth strategies for products like Cortrophin Gel and ILUVIEN.

4:36 PM ET Form 4
Insider Selling

Ani Pharmaceuticals Sr. VP, General Counsel & Sec. Meredith Cook Sells $35.4K of Stock

Meredith Cook, Sr. VP, General Counsel & Sec., sold 500 shares of Ani Pharmaceuticals Inc at $70.80 a share, worth $35.4K in total on Nov 13, 2026. Shares held after the trade: 72,924 (-0.7%).

Value
$35.4K
Shares
500
Price
$70.80
Role
Sr. VP, General Counsel & Sec.
Holding change
-0.7%
Trade date
Nov 13, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.